Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche

Journal of Pathology

Volumn 231, Issue 2, 2013, Pages 236-247

  Harries, Matthew J ^a   Meyer, Katja ^b   Chaudhry, Iskander ^c   E Kloepper, Jennifer ^b   Poblet, Enrique ^d   Griffiths, Christopher E M ^a   Paus, Ralf ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

alopecia; frontal fibrosing alopecia; lichen planopilaris; pathogenesis

Indexed keywords

CD200 ANTIGEN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKERATIN 15; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; INDOLEAMINE 2,3 DIOXYGENASE; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM CELL; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; LASER CAPTURE MICRODISSECTION; LICHEN PLANOPILARIS; MICROARRAY ANALYSIS; MORPHOMETRICS; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCALP; SKIN CULTURE; STEM CELL NICHE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ALOPECIA; FRONTAL FIBROSING ALOPECIA; LICHEN PLANOPILARIS; PATHOGENESIS;

ALOPECIA; EPITHELIAL CELLS; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LICHEN PLANUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELL NICHE; STEM CELLS;

EID: 84883850126     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4233     Document Type: Article

References (81)

1. Ross EK, Tan E, Shapiro J,. Update on primary cicatricial alopecias. J Am Acad Dermatol 2005; 53: 1-37; quiz 38-40.
2. Harries MJ, Trueb RM, Tosti A, et al., How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol 2009; 160: 482-501.
3. Rongioletti F, Christana K,. Cicatricial (scarring) alopecias: an overview of pathogenesis, classification, diagnosis, and treatment. Am J Clin Dermatol 2012; 13: 247-260.
4. Hadshiew IM, Foitzik K, Arck PC, et al., Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 2004; 123: 455-457.
5. Harries MJ, Sinclair RD, Macdonald-Hull S, et al., Management of primary cicatricial alopecias: options for treatment. Br J Dermatol 2008; 159: 1-22.
6. Miteva M, Tosti A,. Treatment options for alopecia: an update, looking to the future. Expert Opin Pharmacother 2012; 13: 1271-1281.
7. Harries MJ, Paus R,. The pathogenesis of primary cicatricial alopecias. Am J Pathol 2010; 177: 2152-2162.
8. Ohyama M., Primary cicatricial alopecia: recent advances in understanding and management. J Dermatol 2012; 39: 18-26.
9. Cotsarelis G, Millar SE,. Towards a molecular understanding of hair loss and its treatment. Trends Mol Med 2001; 7: 293-301.
10. Cotsarelis G., Epithelial stem cells: a folliculocentric view. J Invest Dermatol 2006; 126: 1459-1468.
11. Kloepper JE, Tiede S, Brinckmann J, et al., Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol 2008; 17: 592-609.
12. Myung P, Ito M,. Dissecting the bulge in hair regeneration. J Clin Invest 2012; 122: 448-454.
13. Christoph T, Muller-Rover S, Audring H, et al., The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000; 142: 862-873.
14. Ito T, Ito N, Bettermann A, et al., Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004; 164: 623-634.
15. Ito T, Ito N, Saatoff M, et al., Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 2008; 128: 1196-1206.
16. Paus R, Nickoloff BJ, Ito T,. A 'hairy' privilege. Trends Immunol 2005; 26: 32-40.
17. Breitkopf T, Lo BK, Leung G, et al., Somatostatin expression in human hair follicles and its potential role in immune privilege. J Invest Dermato l 2013; 133: 1722-1730.
18. Meyer KC, Klatte JE, Dinh HV, et al., Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 2008; 159: 1077-1085.
19. Fujisaki J, Wu J, Carlson AL, et al., In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 2011; 474: 216-219.
20. Cotsarelis G., Gene expression profiling gets to the root of human hair follicle stem cells. J Clin Invest 2006; 116: 19-22.
21. Pozdnyakova O, Mahalingam M,. Involvement of the bulge region in primary scarring alopecia. J Cutan Pathol 2008; 35: 922-925.
22. Al-Refu K, Edward S, Ingham E, et al., Expression of hair follicle stem cells detected by cytokeratin 15 stain: implications for pathogenesis of the scarring process in cutaneous lupus erythematosus. Br J Dermatol 2009; 160: 1188-1196.
23. Harries MJ, Meyer KC, Chaudhry IH, et al., Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? Clin Exp Dermatol 2009; 35: 637-644.
24. Ito M, Liu Y, Yang Z, et al., Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 2005; 11: 1351-1354.
25. Karnik P, Tekeste Z, McCormick TS, et al., Hair follicle stem cell-specific PPARγ deletion causes scarring alopecia. J Invest Dermatol 2009; 129: 1243-1257.
26. Mirmirani P, Karnik P,. Lichen planopilaris treated with a peroxisome proliferator-activated receptor γ-agonist. Arch Dermatol 2009; 145: 1363-1366.
27. Griffin LL, Michaelides C, Griffiths CE, et al., Primary cicatricial alopecias: a UK survey. Br J Dermatol 2012; 167: 694-697.
28. Poblet E, Jimenez F, Pascual A, et al., Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol 2006; 45: 375-380.
29. Hutchens KA, Balfour EM, Smoller BR,. Comparison between Langerhans cell concentration in lichen planopilaris and traction alopecia with possible immunologic implications. Am J Dermatopathol 2011; 33: 277-280.
30. Yu M, Bell RH, Ross EK, et al., Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. J Dermatol Sci 2010; 57: 27-36.
31. Baibergenova A, Walsh S,. Use of pioglitazone in patients with lichen planopilaris. J Cutan Med Surg 2012; 16: 97-100.
32. Stenn KS, Karnik P,. Lipids to the top of hair biology. J Invest Dermatol 2010; 130: 1205-1207.
33. Harries MJ, Paus R,. Scarring alopecia and the PPARγ connection. J Invest Dermatol 2009; 129: 1066-1070.
34. Rotondi M, Chiovato L,. The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. Curr Pharm Des 2011; 17: 3202-3216.
35. Hu X, Ivashkiv LB,. Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases. Immunity 2009; 31: 539-550.
36. El-behi M, Rostami A, Ciric B,. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2010; 5: 189-197.
37. Ruckert R, Hofmann U, van der Veen C, et al., MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998; 111: 25-30.
38. Gilhar A, Etzioni A, Paus R,. Alopecia areata. N Engl J Med 2012; 366: 1515-1525.
39. Assouly P, Reygagne P,. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 2009; 28: 3-10.
40. Inchara YK, Tirumalae R, Kavdia R, et al., Histopathology of scarring alopecia in Indian patients. Am J Dermatopathol 2011; 33: 461-467.
41. Ohyama M, Terunuma A, Tock CL, et al., Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006; 116: 249-260.
42. Clement-Ziza M, Munnich A, Lyonnet S, et al., Stabilization of RNA during laser capture microdissection by performing experiments under argon atmosphere or using ethanol as a solvent in staining solutions. RNA 2008; 14: 2698-2704.
43. Lu Z, Hasse S, Bodo E, et al., Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 2007; 16: 37-44.
44. Tiede S, Koop N, Kloepper JE, et al., Nonviral in situ green fluorescent protein labeling and culture of primary, adult human hair follicle epithelial progenitor cells. Stem Cells 2009; 27: 2793-2803.
45. Rosenblum MD, Yancey KB, Olasz EB, et al., CD200, a 'no danger' signal for hair follicles. J Dermatol Sci 2006; 41: 165-174.
46. Waldmann H., Tolerance: an overview and perspectives. Nat Rev Nephrol 2010; 6: 569-576.
47. Niederkorn JY,. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006; 7: 354-359.
48. Kinori M, Kloepper JE, Paus R,. Can the hair follicle become a model for studying selected aspects of human ocular immune privilege? Invest Ophthalmol Vis Sci 2011; 52: 4447-4458.
49. Wahl SM, Wen J, Moutsopoulos N,. TGFβ: a mobile purveyor of immune privilege. Immunol Rev 2006; 213: 213-227.
50. Blanpain C, Sotiropoulou PA,. A dominant role of the hair follicle stem cell niche in regulating melanocyte stemness. Cell Stem Cell 2010; 6: 95-96.
51. +-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J Invest Dermatol 2008; 128: 67-78.
52. Wenzel J, Tuting T,. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in 'interface dermatitis'. J Invest Dermatol 2008; 128: 2392-2402.
53. + T cells plays a major role in the pathogenesis of chronic GVHD. Blood 2012; 120: 4246-4255.
54. Kroeze KL, Boink MA, Sampat-Sardjoepersad SC, et al., Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. J Invest Dermatol 2012; 132: 216-225.
55. Ito T, Hashizume H, Shimauchi T, et al., CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. J Dermatol Sci 2013; 69: 140-147.
56. Ghoreishi M, Vera Kellet C, Dutz JP,. Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea. Exp Dermatol 2012; 21: 417-419.
57. Wenzel J, Proelss J, Wiechert A, et al., CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. J Am Acad Dermatol 2007; 56: 648-650.
58. Wenzel J, Tuting T,. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in 'interface dermatitis'. J Invest Dermatol 2008; 128: 2392-2402.
59. Ko CJ, Srivastava B, Braverman I, et al., Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining. J Cutan Pathol 2011; 38: 889-892.
60. Wenzel J, Zahn S, Bieber T, et al., Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus. Arch Dermatol Res 2009; 301: 83-86.
61. Mobini N, Tam S, Kamino H,. Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype. J Cutan Pathol 2005; 32: 675-679.
62. Sellheyer K, Atanaskova-Mesinkovska N, Nelson P, et al., Differential expression of stem cell markers in lichen planopilaris and alopecia areata. Br J Dermatol 2011; 165: 1149-1151.
63. Tumbar T, Guasch G, Greco V, et al., Defining the epithelial stem cell niche in skin. Science 2004; 303: 359-363.
64. Morris RJ, Liu Y, Marles L, et al., Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 2004; 22: 411-417.
65. Horsley V, Aliprantis AO, Polak L, et al., NFATc1 balances quiescence and proliferation of skin stem cells. Cell 2008; 132: 299-310.
66. Fujiwara H, Ferreira M, Donati G, et al., The basement membrane of hair follicle stem cells is a muscle cell niche. Cell 2011; 144: 577-589.
67. Oshimori N, Fuchs E,. Paracrine TGFβ signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell 2012; 10: 63-75.
68. Lin HY, Yang LT,. Differential response of epithelial stem cell populations in hair follicles to TGFβ signaling. Dev Biol 2012.
69. Meyer KC, Tiede S, Harries M, et al., IFNγ induces bulge immunoprivilege collapse and may cause epithelial stem cell exhaust. J Invest Dermatol 2010; 130: S42.
70. Kang H, Wu WY, Lo BK, et al., Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 2010; 130: 2677-2680.
71. Harries MJ, Sun J, Paus R, et al., Management of alopecia areata. Br Med J 2010; 341: c3671.
72. Zahn S, Rehkamper C, Kummerer BM, et al., Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. J Invest Dermatol 2011; 131: 133-140.
73. McPhee CG, Duncan FJ, Silva KA, et al., Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse. J Invest Dermatol 2012; 132: 1736-1738.
74. Nagao K, Kobayashi T, Moro K, et al., Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol 2012; 13: 744-752.
75. Cooper SM, Ali I, Baldo M, et al., The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432-1435.
76. Danielsson K, Ebrahimi M, Wahlin YB, et al., Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol 2012; 26: 1415-1419.
77. Lavanya N, Jayanthi P, Rao UK, et al., Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol 2011; 15: 127-132.
78. Shiohara T, Mizukawa Y, Takahashi R, et al., Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells. Curr Dir Autoimmun 2008; 10: 206-226.
79. Sugerman PB, Savage NW, Walsh LJ, et al., The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13: 350-365.
80. Garza LA, Yang CC, Zhao T, et al., Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. J Clin Invest 2011; 121: 613-622.
81. Magerl M, Tobin DJ, Muller-Rover S, et al., Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. J Invest Dermatol 2001; 116: 947-955.